Table 2.
Lifetime risk (95% CI) | ||
---|---|---|
Disease | Women | Men |
RA | 3.64 (3.37, 3.90) | 1.68 (1.41, 1.94) |
RF+ RA | 2.39 (2.18, 2.60) | 1.13 (0.91, 1.33) |
SLE | 0.91 (0.75, 1.06) | 0.21 (0.06, 0.42) |
PsA | 0.46 (0.33, 0.59) | 0.62 (0.51, 0.72) |
PMR | 2.43 (2.15, 2.72) | 1.66 (1.32, 2.00) |
GCA | 1.04 (0.90, 1.16) | 0.51 (0.27, 0.64) |
AS | 0.08 (0.00, 0.19) | 0.63 (0.53, 0.74) |
Primary SS | 0.75 (0.67, 0.83) | 0.04 (0.00, 0.10) |
Primary inflammatory autoimmune rheumatic disease* | 8.42 (7.98, 8.83) | 5.13 (4.64, 5.64) |
RA = rheumatoid arthritis; RF+ = rheumatoid factor positive; SLE = systemic lupus erythematosus; PsA = psoriatic arthritis; PMR = polymyalgia rheumatica; GCA = giant cell arteritis; AS = ankylosing spondylitis; SS = Sjögrens syndrome; CI = confidence interval
Primary inflammatory autoimmune rheumatic disease is defined as the first of any of these rheumatic diseases